Patents by Inventor Isabelle Chambaud

Isabelle Chambaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9408878
    Abstract: The present invention concerns strains of Lactococcus lactis capable of inhibiting the growth of a pathogenic microorganism and/or improving the intestinal epithelial barrier integrity. These strains are suitable for use in the treatment or prevention of a digestive disorder.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: August 9, 2016
    Assignee: Compagnie Gervais Danone
    Inventors: Isabelle Chambaud, Biliana Lesic
  • Patent number: 9402872
    Abstract: The invention relates to the use of lactic acid bacteria, for use in improving transepithelial resistance and more particularly in treating and/or preventing constipation and/or irritable bowel disease.
    Type: Grant
    Filed: May 30, 2011
    Date of Patent: August 2, 2016
    Assignee: Compagnie Gervais Danone
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Isabelle Chambaud, Biliana Lesic
  • Publication number: 20160045557
    Abstract: The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.
    Type: Application
    Filed: October 29, 2015
    Publication date: February 18, 2016
    Applicant: COMPAGNE GERVAIS DANONE
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Isabelle Chambaud, Tamara Smokvina, Marie-Christine Degivry, Biliana Lesic, Michel Neunlist
  • Patent number: 9198940
    Abstract: The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.
    Type: Grant
    Filed: May 27, 2011
    Date of Patent: December 1, 2015
    Assignee: Compagnie Gervais Danone
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Isabelle Chambaud, Tamara Smokvina, Marie-Christine Degivry, Biliana Lesic, Michel Neunlist
  • Patent number: 9056123
    Abstract: The present invention relates to specific Lactobacillus strains with an anti-oxidant effect.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: June 16, 2015
    Assignee: Compagnie Gervais Danone
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaƫlle Bourdet-Sicard
  • Patent number: 8735089
    Abstract: The present invention relates to a method using Caenorhabditis elegans for screening of food grade bacteria which have a protective effect against oxidative stress.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: May 27, 2014
    Assignees: Compagnie Gervais Danone, Biopolis S.L.
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Daniel Ramon Vidal, Patricia Martorell Guerola, Nuria Gonzalez Martinez, Salvador Genoves Martinez, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaelle Bourdet-Sicard
  • Patent number: 8697054
    Abstract: The invention relates to a novel strain of Lactobacillus rhamnosus, having antimicrobial and immunomodulatory properties, and to compositions containing said strain.
    Type: Grant
    Filed: March 18, 2009
    Date of Patent: April 15, 2014
    Assignee: Campagnie Gervais Danone
    Inventors: Isabelle Chambaud, Artem Khlebnikov, Anne-Catherine Villain, Gianfranco Grompone, Thierry Saint Denis
  • Patent number: 8685388
    Abstract: The present invention relates to a method for the prevention, treatment and reduction of gastro-intestinal inflammation in a subject by administering a specific Bifidobacterium bacteria, in particular a fermented dairy product comprising said specific Bifidobacterium bacteria for the prevention, treatment and reduction of gastro-intestinal inflammation, in particular for the prevention and treatment of inflammatory bowel disease (IBD), ulcerative colitis (UC) and/or Crohn's Disease (CD) and for the prevention and treatment of Irritable Bowel Syndrome (IBS).
    Type: Grant
    Filed: November 2, 2009
    Date of Patent: April 1, 2014
    Assignees: Compagnie Gervais Danone, President and Fellows of Harvard College
    Inventors: Patrick Veiga, Isabelle Chambaud, Artem Khlebnikov, Laurie H. Glimcher, Wendy S. Garrett
  • Publication number: 20130336944
    Abstract: The present invention concerns strains of Lactococcus lactis capable of inhibiting the growth of a pathogenic microorganism and/or improving the intestinal epithelial barrier integrity. These strains are suitable for use in the treatment or prevention of a digestive disorder.
    Type: Application
    Filed: December 17, 2010
    Publication date: December 19, 2013
    Applicant: COMPAGNIE GERVAIS DANONE
    Inventors: Isabelle Chambaud, Biliana Lesic
  • Patent number: 8557561
    Abstract: The invention relates to a novel strain of Lactobacillus paracasei subspecies paracasei, having antimicrobial and immunomodulatory properties, and to compositions containing said strain.
    Type: Grant
    Filed: April 16, 2009
    Date of Patent: October 15, 2013
    Assignee: Compagnie Gervais Danone
    Inventors: Isabelle Chambaud, Artem Khlebnikov, Anne-Catherine Villain, Gianfranco Grompone, Thierry Saint Denis, Anne Druesne, Tamara Smokvina
  • Publication number: 20130216510
    Abstract: The invention relates to the use of lactic acid bacteria, for use in improving transepithelial resistance and more particularly in treating and/or preventing constipation and/or irritable bowel disease.
    Type: Application
    Filed: May 30, 2011
    Publication date: August 22, 2013
    Applicant: COMPAGNIE GERVAIS DANONE
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Isabelle Chambaud, Biliana Lesic
  • Publication number: 20130195822
    Abstract: The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.
    Type: Application
    Filed: May 27, 2011
    Publication date: August 1, 2013
    Applicant: COMPAGNIE GERVAIS DANONE
    Inventors: Sophie Legrain-Raspaud, Gianfranco Grompone, Sandrine Capronnier, Isabelle Chambaud, Tamara Smokvina, Marie-Christine Degivry, Biliana Lesic, Michel Neunlist
  • Publication number: 20130171117
    Abstract: The present invention relates to specific Lactobacillus strains with an anti-oxidant effect.
    Type: Application
    Filed: January 8, 2010
    Publication date: July 4, 2013
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaƫlle Bourdet-Sicard
  • Publication number: 20130078187
    Abstract: The present invention relates to a method using Caenorhabditis elegans for screening of food grade bacteria which have a protective effect against oxidative stress.
    Type: Application
    Filed: January 8, 2010
    Publication date: March 28, 2013
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Daniel Ramon Vidal, Patricia Martorell Guerola, Nuria Gonzalez Martinez, Salvador Genoves Martinez, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaelle Bourdet-Sicard
  • Publication number: 20120308523
    Abstract: The present invention relates to a method for the prevention, treatment and reduction of gastro-intestinal inflammation in a subject by administering a specific Bifidobacterium bacteria, in particular a fermented dairy product comprising said specific Bifidobacterium bacteria for the prevention, treatment and reduction of gastro-intestinal inflammation, in particular for the prevention and treatment of inflammatory bowel disease (IBD), ulcerative colitis (UC) and/or Crohn's Disease (CD) and for the prevention and treatment of Irritable Bowel Syndrome (IBS).
    Type: Application
    Filed: November 2, 2009
    Publication date: December 6, 2012
    Applicants: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, COMPAGNIE GERVAIS DANONE
    Inventors: Patrick Veiga, Isabelle Chambaud, Artem Khlebnikov, Laurie H. Glimcher, Wendy S. Garrett
  • Publication number: 20110150852
    Abstract: The invention relates to a novel strain of Lactobacillus paracasei subspecies paracasei, having antimicrobial and immunomodulatory properties, and to compositions containing said strain.
    Type: Application
    Filed: April 16, 2009
    Publication date: June 23, 2011
    Inventors: Isabelle Chambaud, Artem Khlebnikov, Anne-Catherine Villain, Gianfranco Grompone, Thierry Saint Denis, Anne Druesne, Tamara Smokvina
  • Publication number: 20110059058
    Abstract: The invention relates to a novel strain of Lactobacillus rhamnosus, having antimicrobial and immunomodulatory properties, and to compositions containing said strain.
    Type: Application
    Filed: March 18, 2009
    Publication date: March 10, 2011
    Inventors: Isabelle Chambaud, Artem Khlebnikov, Ann-Catherine Villain, Gianfranco Grompone, Thierry Saint Denis